These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 16368948

  • 1. Re: Limits of predictive models using microarray data for breast cancer clinical treatment outcome.
    Jansen MP, Foekens JA, Klijn JG, Berns EM.
    J Natl Cancer Inst; 2005 Dec 21; 97(24):1851-2; author reply 1852-3. PubMed ID: 16368948
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
    Maier S, Nimmrich I, Koenig T, Eppenberger-Castori S, Bohlmann I, Paradiso A, Spyratos F, Thomssen C, Mueller V, Nährig J, Schittulli F, Kates R, Lesche R, Schwope I, Kluth A, Marx A, Martens JW, Foekens JA, Schmitt M, Harbeck N, European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
    Eur J Cancer; 2007 Jul 21; 43(11):1679-86. PubMed ID: 17601725
    [Abstract] [Full Text] [Related]

  • 4. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Møller S, Ejlertsen B, Mouridsen HT.
    Acta Oncol; 2009 Jul 21; 48(4):522-31. PubMed ID: 19173092
    [Abstract] [Full Text] [Related]

  • 5. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.
    J Natl Cancer Inst; 2008 Oct 01; 100(19):1380-8. PubMed ID: 18812550
    [Abstract] [Full Text] [Related]

  • 6. RE: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.
    Sgroi DC, Haber DA, Ryan PD, Ma XJ, Erlander MG.
    Cancer Cell; 2004 Nov 01; 6(5):445. PubMed ID: 15542428
    [No Abstract] [Full Text] [Related]

  • 7. Genomic testing for sensitivity of breast cancer to hormonal therapy.
    Symmans WF.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):1954-5. PubMed ID: 16609001
    [No Abstract] [Full Text] [Related]

  • 8. Individualized care for patients with cancer - a work in progress.
    Bast RC, Hortobagyi GN.
    N Engl J Med; 2004 Dec 30; 351(27):2865-7. PubMed ID: 15591336
    [No Abstract] [Full Text] [Related]

  • 9. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
    Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, Kristiansen G, Paradiso A, Hartmann O, Margossian A, Martens J, Schwope I, Lukas A, Müller V, Milde-Langosch K, Nährig J, Foekens J, Maier S, Schmitt M, Lesche R.
    J Clin Oncol; 2008 Nov 01; 26(31):5036-42. PubMed ID: 18711169
    [Abstract] [Full Text] [Related]

  • 10. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.
    J Clin Oncol; 2008 Mar 20; 26(9):1404-10. PubMed ID: 18349391
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.
    Linke SP, Bremer TM, Herold CD, Sauter G, Diamond C.
    Clin Cancer Res; 2006 Feb 15; 12(4):1175-83. PubMed ID: 16489071
    [Abstract] [Full Text] [Related]

  • 14. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
    J Natl Cancer Inst Monogr; 2006 Feb 15; (36):7-15. PubMed ID: 17032888
    [Abstract] [Full Text] [Related]

  • 15. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L, Coudert B, Fumoleau P.
    J Clin Oncol; 2009 Jun 01; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cancer is heterogeneous.
    Guinebretiere JM.
    J Clin Oncol; 2009 Jun 01; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
    Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, A'Hern R, Salter J, Detre S, Hills M, Walsh G, IMPACT Trialists Group.
    J Natl Cancer Inst; 2007 Jan 17; 99(2):167-70. PubMed ID: 17228000
    [Abstract] [Full Text] [Related]

  • 19. Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
    van Agthoven T, Sieuwerts AM, Meijer-van Gelder ME, Look MP, Smid M, Veldscholte J, Sleijfer S, Foekens JA, Dorssers LC.
    J Clin Oncol; 2009 Feb 01; 27(4):542-9. PubMed ID: 19075277
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen.
    Muss HB, Bunn JY, Crocker A, Plaut K, Koh J, Heintz N, Rincon M, Weaver DL, Tam D, Beatty B, Kaufman P, Donovan M, Verbel D, Weiss L.
    Breast J; 2007 Feb 01; 13(4):337-45. PubMed ID: 17593037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.